Obeticholic acid (OCA) licensing in the UK – update following European Medicines Agency decision
This blog was last updated on 19th December 2024 (see below) On 28th June 2024 the European Medicines Agency (EMA) announced that they were recommending that obeticholic acid (OCA), brand name Ocaliva, be taken off the market in the EU. OCA is a treatment for primary...
British Liver Trust warns of fatty liver disease tsunami, due to the link between fatty liver disease and type 2 diabetes
Two-thirds of people living with type 2 diabetes also have fatty liver disease[i] – but they may not be aware of it, warns the British Liver Trust. Fatty liver disease also significantly heightens the risk of developing type 2 diabetes. The charity urges people to...
Making sure you can get your medicines
Suddenly stopping a prescription medicine can make your liver disease worse. But with the current pressures on NHS services, some patients are finding it hard to get a new prescription in time. This can have serious consequences. Patients who have gone home from...
Love Your Liver roadshow visits the Holyrood Parliament in Scotland
The Love Your Liver roadshow visited the Scottish Parliament on the 21st of May to call for bolder action on prevention and early detection of liver disease from the Scottish Government and Health Boards. Over 20 MSPs were represented at the event, including the...